C. Dhar, A. Sasmal, A. Varki, and . From, Serum Sickness" to "Xenosialitis": past, present, and future significance of the non-human sialic acid Neu5Gc, Front Immunol, vol.10, p.807, 2019.

R. Schauer, H. J. Schoop, and H. Faillard,

, Hoppe Seylers Z Physiol Chem, vol.349, pp.645-52, 1968.

O. M. Pearce and H. Läubli, Sialic acids in cancer biology and immunity, Glycobiology, vol.26, pp.111-139, 2016.

A. N. Samraj, O. M. Pearce, H. Läubli, A. N. Crittenden, A. K. Bergfeld et al., A red meat-derived glycan promotes inflammation and cancer progression, Proc Natl Acad Sci, vol.112, pp.542-549, 2015.

K. Kawanishi, C. Dhar, R. Do, N. Varki, P. Gordts et al., Human species-specific loss of CMP-N -acetylneuraminic acid hydroxylase enhances atherosclerosis via intrinsic and extrinsic mechanisms, Proc Natl Acad Sci, vol.116, pp.16036-16081, 2019.

J. P. Soulillou, E. Cozzi, C. Galli, and J. M. Bach, Can we extrapolate from a Cmah (-/-) Ldlr (-/-) mouse model a susceptibility for atherosclerosis in humans?, Proc Natl Acad Sci, vol.117, pp.1845-1851, 2020.
URL : https://hal.archives-ouvertes.fr/inserm-02490623

K. Kawanishi, C. Dhar, A. Varki, and P. Gordts, Reply to soulillou et al.: difficulties in extrapolating from animal models exemplify unusual human atherosclerosis susceptibility and mechanisms via CMAH loss, Proc Natl Acad Sci, vol.117, pp.1847-1855, 2020.

P. Tangvoranuntakul, P. Gagneux, S. Diaz, M. Bardor, N. Varki et al., Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid, Proc Natl Acad Sci, vol.100, pp.12045-50, 2003.

L. Berre, L. Danger, R. Mai, H. L. Amon, R. et al., Elicited and pre-existing anti-Neu5Gc antibodies differentially affect human endothelial cells transcriptome, Xenotransplantation, vol.26, p.12535, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-02337077

S. Inoue, C. Sato, and K. Kitajima, Extensive enrichment of Nglycolylneuraminic acid in extracellular sialoglycoproteins abundantly synthesized and secreted by human cancer cells, Glycobiology, vol.20, pp.752-62, 2010.

M. Labrada, D. Dorvignit, G. Hevia, N. Rodríguez-zhurbenko, A. M. Hernández et al., GM3(Neu5Gc) ganglioside: an evolution fixed neoantigen for cancer immunotherapy, Semin Oncol, vol.45, pp.41-51, 2018.

V. Padler-karavani, N. Hurtado-ziola, M. Pu, H. Yu, S. Huang et al., Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer, Cancer Res, vol.71, pp.3352-63, 2011.

K. Banda, C. J. Gregg, R. Chow, N. M. Varki, and A. Varki, Metabolism of vertebrate amino sugars with N-glycolyl groups: mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen N-glycolylneuraminic acid, J Biol Chem, vol.287, pp.28852-64, 2012.

L. S. Zaramela, C. Martino, F. Alisson-silva, S. D. Rees, S. L. Diaz et al., Gut bacteria responding to dietary change encode sialidases that exhibit preference for red meat-associated carbohydrates, Nat Microbiol, vol.4, pp.2082-2091, 2019.

A. S. Kooner, H. Yu, and X. Chen, Synthesis of N-glycolylneuraminic acid (Neu5Gc) and Its glycosides, Front Immunol, vol.10, 2004.

P. Obukhova, S. Tsygankova, A. Chinarev, N. Shilova, A. Nokel et al., Are there specific antibodies against Neu5Gc epitopes in the blood of healthy individuals?, Glycobiology, 2020.

T. Pham, C. J. Gregg, F. Karp, R. Chow, V. Padler-karavani et al., Evidence for a novel human-specific xeno-auto-antibody response against vascular endothelium, Blood, vol.114, pp.5225-5260, 2009.

A. Salama, G. Evanno, N. Lim, J. Rousse, L. Berre et al., Anti-Gal and anti-Neu5Gc responses in nonimmunosuppressed patients after treatment with rabbit antithymocyte polyclonal IgGs, Transplantation, vol.101, pp.2501-2508, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02156016

R. E. Taylor, C. J. Gregg, V. Padler-karavani, D. Ghaderi, H. Yu et al., Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid, J Exp Med, vol.207, pp.1637-1683, 2010.

A. Visekruna, S. Hartmann, Y. R. Sillke, R. Glauben, F. Fischer et al., Intestinal development and homeostasis require activation and apoptosis of diet-reactive T cells, J Clin Invest, vol.129, pp.1972-83, 2019.

A. N. Samraj, K. A. Bertrand, R. Luben, Z. Khedri, H. Yu et al., Polyclonal human antibodies against glycans bearing red meatderived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: total antibody levels are associated with colorectal cancer risk, PLoS ONE, vol.13, p.197464, 2018.

L. Scobie, V. Padler-karavani, L. Bas-bernardet, S. Crossan, C. Blaha et al., Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts, J Immunol, vol.191, pp.2907-2922, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02166106

A. Salama, G. Evanno, J. Harb, and J. P. Soulillou, Potential deleterious role of anti-Neu5Gc antibodies in xenotransplantation, Xenotransplantation, vol.22, pp.85-94, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02147779

R. Amon, S. L. Ben-arye, L. Engler, H. Yu, N. Lim et al., Glycan microarray reveal induced IgGs repertoire shift against a dietary carbohydrate in response to rabbit anti-human thymocyte therapy, Oncotarget, vol.8, pp.112236-112280, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01885572

G. Couvrat-desvergnes, A. Salama, L. Berre, L. Evanno, G. Viklicky et al., Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival, J Clin Invest, vol.125, pp.4655-65, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02147235

F. J. Dixon and P. H. Mauer, Effects of large infusions of heterologous serum proteins on the serum protein metabolism of rabbits, J Exp Med, vol.101, pp.233-277, 1955.

S. E. Gitelman, P. A. Gottlieb, M. R. Rigby, E. I. Felner, S. M. Willi et al., Antithymocyte globulin treatment for patients with recentonset type 1 diabetes: 12-month results of a randomised, placebocontrolled, phase 2 trial, Lancet Diabetes Endocrinol, vol.1, pp.306-322, 2013.

J. P. Soulillou, C. Süsal, B. Döhler, and G. Opelz, No increase in colon cancer risk following induction with Neu5Gc-bearing rabbit Anti-T Cell IgG (ATG) in recipients of kidney transplants, Cancers, vol.10, p.324, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02157540

V. Padler-karavani, A. H. Tremoulet, H. Yu, X. Chen, J. C. Burns et al., A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki disease, PLoS ONE, vol.8, p.58443, 2013.

L. Berre, L. Rousse, J. Gourraud, P. A. Imbert-marcille, B. M. Salama et al., Decrease of blood anti-?1,3 galactose abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patients, Clin Immunol, vol.180, pp.128-163, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01560209

J. M. Sroga, D. H. Wu, F. Ma, E. Tecle, S. Reynoso et al., Detection of the dietary xenoglycan N-glycolylneuraminic acid (Neu5Gc) and anti-Neu5Gc antibodies within reproductive tracts of male and female infertility subjects, Clin Obstet Gynecol Reprod Med, vol.1, pp.72-80, 2015.

R. Frei, C. Roduit, R. Ferstl, L. O'mahony, and R. P. Lauener, Exposure of children to rural lifestyle factors associated with protection against allergies induces an anti-Neu5Gc antibody response, Front Immunol, vol.10, p.1628, 2019.

K. F. Boligan, J. Oechtering, C. W. Keller, B. Peschke, R. Rieben et al., Xenogeneic Neu5Gc and self-glycan Neu5Ac epitopes are potential immune targets in MS, Neurol Neuroimmunol Neuroinflamm, vol.7, p.676, 2020.

P. A. Bousquet, J. A. Sandvik, J. Edin, N. F. Krengel, and U. , Hypothesis: hypoxia induces de novo synthesis of NeuGc gangliosides in humans through CMAH domain substitute, Biochem Biophys Res Commun, vol.495, pp.1562-1568, 2018.

C. F. Bryan, W. S. Cherikh, and D. A. Sesok-pizzini, A2 /A2 B to B renal transplantation: past, present, and future directions, Am J Transplant, vol.16, pp.11-20, 2016.

G. Bussone, H. Dib, J. D. Dimitrov, L. Camoin, C. Broussard et al., Identification of target antigens of self-reactive IgG in intravenous immunoglobulin preparations, Proteomics, vol.9, pp.2253-62, 2009.

S. Avrameas, Autopolyreactivity confers a holistic role in the immune system, Scand J Immunol, vol.83, pp.227-261, 2016.

A. Ascherio, K. L. Munger, E. T. Lennette, D. Spiegelman, M. A. Hernán et al., Epstein-barr virus antibodies and risk of multiple sclerosis: a prospective study, JAMA, vol.286, pp.3083-3091, 2001.

J. P. Soulillou, Missing links in multiple sclerosis etiology. A working connecting hypothesis, vol.80, pp.509-525, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02165738